Overview

Financials

News Ideas Discussions Technicals Forecast Seasonals

ENVB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪2.99 M‬USD

—

−13.34USD

1994

Joseph Tucker

enveric.com

About

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.

Ownership

‪‪2.47 M‬‬

Free Float shares

‪‪2.14 M‬‬ (86.73%)

Closely held shares

‪‪328.00 K‬‬ (13.27%)

Free Float shares

‪‪2.14 M‬‬ (86.73%)

Closely held shares

‪‪328.00 K‬‬ (13.27%)

Capital structure

Market cap

‪‪2.99 M‬‬

Cash & equivalents

‪‪4.29 M‬‬

Enterprise value

‪‪−1.30 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪2.99 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Valuation ratios

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Growth and Profitability

Company’s recent performance and margins

Performance

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−3.20 M‬‬

‪‪−2.40 M‬‬

‪‪−1.60 M‬‬

‪‪−800.00 K‬‬

‪0.00‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪‪−2.40 M‬‬

‪‪−1.80 M‬‬

‪‪−1.20 M‬‬

‪‪−600.00 K‬‬

‪0.00‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪‪−2.40 M‬‬

‪‪−1.80 M‬‬

‪‪−1.20 M‬‬

‪‪−600.00 K‬‬

‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0.00‬

Actual

Estimate

Earnings

Next:Aug 18, 2025

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪−8.40‬

‪−6.30‬

‪−4.20‬

‪−2.10‬

‪0.00‬

Actual

Estimate

Dividends

Dividend yield, history and sustainability

No dividends

ENVB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−3.00 M‬‬

‪0.00‬

‪‪3.00 M‬‬

‪‪6.00 M‬‬

‪‪9.00 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

Short term

Long term

‪0.00‬

‪‪1.30 M‬‬

‪‪2.60 M‬‬

‪‪3.90 M‬‬

‪‪5.20 M‬‬

Assets

Liabilities